<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>200(3)</volume><submitter>Majewski W</submitter><pubmed_abstract>&lt;h4>Purpose&lt;/h4>Local recurrences after radical prostatectomy (RP) and postoperative radiotherapy (RT) are challenging for salvage treatment. Retrospective analysis of own experiences with salvage re-irradiation was performed.&lt;h4>Methods&lt;/h4>The study included all consecutive patients treated with salvage stereotactic body radiotherapy (sSBRT) for prostate bed recurrence following RP and postoperative RT at a single tertiary center between 2014 and 2021. Treatment toxicity defined as the occurrence of CTCAE grade ≥ 2 genito-urinary (GU) or gastro-intestinal (GI) adverse events (AEs) was assessed. A PSA response, biochemical control (BC) and overall survival (OS) were also evaluated.&lt;h4>Results&lt;/h4>The study group included 32 patients with a median age of 68 years and a median follow-up of </pubmed_abstract><journal>Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]</journal><pagination>230-238</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10876733</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Stereotactic body radiotherapy (SBRT) re-irradiation for local failures following radical prostatectomy and post-operative radiotherapy.</pubmed_title><pmcid>PMC10876733</pmcid><pubmed_authors>Graupner D</pubmed_authors><pubmed_authors>Goc B</pubmed_authors><pubmed_authors>Goldner G</pubmed_authors><pubmed_authors>Napieralska A</pubmed_authors><pubmed_authors>Majewski W</pubmed_authors><pubmed_authors>Miszczyk M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Stereotactic body radiotherapy (SBRT) re-irradiation for local failures following radical prostatectomy and post-operative radiotherapy.</name><description>&lt;h4>Purpose&lt;/h4>Local recurrences after radical prostatectomy (RP) and postoperative radiotherapy (RT) are challenging for salvage treatment. Retrospective analysis of own experiences with salvage re-irradiation was performed.&lt;h4>Methods&lt;/h4>The study included all consecutive patients treated with salvage stereotactic body radiotherapy (sSBRT) for prostate bed recurrence following RP and postoperative RT at a single tertiary center between 2014 and 2021. Treatment toxicity defined as the occurrence of CTCAE grade ≥ 2 genito-urinary (GU) or gastro-intestinal (GI) adverse events (AEs) was assessed. A PSA response, biochemical control (BC) and overall survival (OS) were also evaluated.&lt;h4>Results&lt;/h4>The study group included 32 patients with a median age of 68 years and a median follow-up of </description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-06-17T06:29:19.599Z</modification><creation>2025-04-05T23:49:32.726Z</creation></dates><accession>S-EPMC10876733</accession><cross_references><pubmed>38157016</pubmed><doi>10.1007/s00066-023-02187-2</doi></cross_references></HashMap>